Virax Biolabs Group Limited(VRAX)

Biotechnology · Lanarkshire, SC

$2.03-0.37 (-15.42%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T20:48:44.253Z.

Stored calculation inputs

Calculation as of: 2026-10-06T20:48:44.253Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-03-31: N/A
Quote price: 2.03

FMP input reference: 76ce780248c1f493ccbdb0751af92273333f1ee075484263629f1dd5eb2dbf7e

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

VRAX Earnings Yield Metrics

EARNINGS YIELD

N/A

VRAX Competitors' Earnings Yield

VRAX

Virax Biolabs Group Limited

Current

Market Cap

$378849.00

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NIKI

Niki BioSolutions, Inc.

vs VRAX

Market Cap

$403887.00

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

XRTX

XORTX Therapeutics Inc.

vs VRAX

Market Cap

$481786.00

Earnings Yield

N/A

TTM Avg

79.57%

3Y Avg

139.63%

5Y Avg

139.63%

SPRC

SciSparc Ltd.

vs VRAX

Market Cap

$250443.00

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

VIVS

VivoSim Labs, Inc.

vs VRAX

Market Cap

$518606.00

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HCWB

HCW Biologics Inc.

vs VRAX

Market Cap

$545796.00

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SLXN

Silexion Therapeutics Ltd.

vs VRAX

Market Cap

$110112.00

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PBM

Psyence Biomedical Ltd.

vs VRAX

Market Cap

$95475.00

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SXTC

China SXT Pharmaceuticals, Inc.

vs VRAX

Market Cap

$667469.00

Earnings Yield

N/A

TTM Avg

0.00%

3Y Avg

0.00%

5Y Avg

0.00%

PRFX

PRF Technologies Ltd.

vs VRAX

Market Cap

$70884.00

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Virax Biolabs Group Limited (VRAX)	$378849.00	N/A	N/A	N/A	N/A
Niki BioSolutions, Inc. (NIKI)vs ›	$403887.00	N/A	N/A	N/A	N/A
XORTX Therapeutics Inc. (XRTX)vs ›	$481786.00	N/A	79.57%	139.63%	139.63%
SciSparc Ltd. (SPRC)vs ›	$250443.00	N/A	N/A	N/A	N/A
VivoSim Labs, Inc. (VIVS)vs ›	$518606.00	N/A	N/A	N/A	N/A
HCW Biologics Inc. (HCWB)vs ›	$545796.00	N/A	N/A	N/A	N/A
Silexion Therapeutics Ltd. (SLXN)vs ›	$110112.00	N/A	N/A	N/A	N/A
Psyence Biomedical Ltd. (PBM)vs ›	$95475.00	N/A	N/A	N/A	N/A
China SXT Pharmaceuticals, Inc. (SXTC)vs ›	$667469.00	N/A	0.00%	0.00%	0.00%
PRF Technologies Ltd. (PRFX)vs ›	$70884.00	N/A	N/A	N/A	N/A

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Earnings Yield: N/A

VRAX Earnings Yield Metrics

VRAX Competitors' Earnings Yield

Earnings Yield vs P/E Ratio

Earnings Yield Formula & Definition

Related Metrics